Are many people who took experimental coronavirus “vaccine” shots being diagnosed with serious medical conditions? It is an important question to ask when evaluating the much repeated by politicians and the big money media claim that the shots are safe.
Children’s Health Defense sought answers directly from the shot takers by commissioning a poll from John Zogby Strategies that was conducted from July 22 through July 24.
Children’s Health Defense lays out some of the results in a Thursday article at its website. The article starts with the following:
More than two years after Operation Warp Speed began, Children’s Health Defense (CHD) commissioned John Zogby Strategies to conduct two surveys about attitudes and the overall health of American adults.Notably, the polled individuals do not include people under the age of 18. Children, now down to the age of six months old, are the latest target for the campaign to pressure everyone to receive the shots. Also, of course, people who have died after receiving the shots cannot take part in polls.
The first survey of 1,038 adults found that 67% of respondents received one or more COVID-19 vaccines, while 33% are unvaccinated. Furthermore, among those vaccinated, 6% received one dose, 28% received two doses, 21% received three doses, and 12% took four or more.
Of those receiving a COVID-19 vaccine, 15% say they’ve been diagnosed by a medical practitioner with a new condition within a matter of weeks to several months after taking the vaccine.
A follow-up question provided a list of medical conditions and asked diagnosed respondents to “select all that apply.” Among those who were medically diagnosed with a new condition within a matter of weeks to several months after receiving a COVID-19 vaccine, the top five cited conditions were:
21% blood clots
19% heart attack
18% liver damage
15% stroke
from Peace and Prosperity http://www.ronpaulinstitute.org/archives/peace-and-prosperity/2022/july/31/new-poll-seeks-answers-about-health-problem-diagnoses-after-safe-coronavirus-shots/
